Caribou is a clinical-stage biotech that specializes in CRISPR gene-editing therapies. Caribou said it had $291 million in cash at the end of the first quarter. The company has a pipeline that ...

John Butcher has been at the helm of Caribou Coffee over an eventful seven years. Under his tenure, the Brooklyn Center-based coffee chain launched a new domestic franchising program and underwent ...

Caribou Biosciences is winnowing down for the second time in the last year, dropping a leukemia CAR-T asset and laying off 32% of staff to home in on two lead allogeneic cell therapy candidates. The ...

BERKELEY, Calif.--(BUSINESS WIRE)--Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced today the execution of an exclusive license agreement with ...